Devices

Dorsal column stimulation for chronic pain, first reported in 1967 after the 1965 gate control theory. How leads, power sources and stimulation patterns changed over fifty years, and what the mechanism debate looks like now.

Device — Other

Spinal cord stimulation (history)

Official site →

SCS · spinal cord stimulation · chronic pain · gate control · Shealy · history · academic · human

Spinal cord stimulation (history)

One-line verdict: A device built on a theory that the field now treats as only part of the story, and still widely used after more than fifty years.

Quick tags: Stimulation · Spinal cord · Human · First reported 1967

Overview

What it is: Electrical pulses delivered to the dorsal columns of the spinal cord to modulate pain pathways. For the epidural spinal cord interface used with a brain implant to restore walking, see the brain-spine interface entry.

History (as reported):

  • 1965: Melzack and Wall proposed the gate control theory of pain. In this model, activation of large-diameter A-beta fibers suppresses nociceptive C-fiber input through inhibitory interneurons in the dorsal horn.
  • 1967: Shealy and colleagues reported the first clinical use: “Electrical inhibition of pain by stimulation of the dorsal columns: Preliminary clinical report,” Anesthesia and Analgesia 46:489-491. One review says the stimulation was first surgically implanted in 1967 by Shealy.
  • 2017: marked 50 years since the first reported use, per a 2019 review.

How the technology changed (2024 timeline review, as summarized in its abstract): Lead design moved from paddle type to percutaneous, with more electrode contacts. Stimulators moved from wireless power to internally powered and rechargeable, with miniaturized components and programmable multichannel devices. Stimulation options expanded to burst and kilohertz frequencies. Usage features added remote programming and MRI compatibility. The review covers FDA milestones for chronic pain and includes other indications, such as a motor disorder in multiple sclerosis, where they affected technology development.

Indications named in a 2019 review: failed back surgery syndrome, chronic regional pain syndrome, neuropathic pain, visceral abdominal pain and intractable angina pectoris.

Mechanism: The gate control theory is described as a foundational model that is only one component of a more complex picture. Reviews list effects at dorsal horn interneurons and supraspinal networks, and proposals include modulation of wide-dynamic-range neurons, cortical and subcortical regions, and descending inhibitory pathways.

Limits: This is a history entry. The sources read here did not give lead dimensions, contact counts or FDA approval years, so those are left out and there is no 3D model.

Spec Card Grid

Timeline

  • 1965: gate control theory, Melzack and Wall
  • 1967: first reported clinical use, Shealy and colleagues
  • 2017: 50th anniversary of first reported use
  • Leads: paddle to percutaneous, more contacts
  • Power: wireless to internal, rechargeable
  • Stimulation: programmable multichannel, burst, kilohertz

Evidence and limits

  • Not covered here: FDA approval years, lead and contact dimensions; no 3D model yet

References